1581 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Conditions: B Acute Lymphoblastic Leukemia;   B Lymphoblastic Lymphoma;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent B Lymphoblastic Lymphoma;   Recurrent T Lymphoblastic Leukemia/Lymphoma;   Refractory B Lymphoblastic Lymphoma;   Refractory T Lymphoblastic Lymphoma;   T Acute Lymphoblastic Leukemia;   T Lymphoblastic Lymphoma
Interventions: Drug: Asparaginase;   Drug: Cyclophosphamide;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Drug: Prednisone;   Biological: Rituximab;   Drug: Vincristine Sulfate
22 Not yet recruiting Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia (CLL)
Interventions: Drug: Idelalisib;   Drug: BI 836826
23 Not yet recruiting A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Obinutuzumab;   Drug: Ibrutinib
24 Not yet recruiting Dose Optimization Study of Idelalisib in Follicular Lymphoma and Small Lymphocytic Lymphoma
Conditions: Follicular Lymphoma;   Small Lymphocytic Lymphoma
Intervention: Drug: Idelalisib
25 Not yet recruiting Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA)
Conditions: Periodic Fever;   Aphthous Stomatitis;   Pharyngitis;   Cervical Adenitis
Interventions: Biological: Lactobacillus acidophilus and Bifidobacterium lactis;   Other: Placebo
26 Recruiting Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
Conditions: Acute Lymphoblastic Leukemia;   Lymphoblastic Lymphoma
Interventions: Drug: Velcade;   Drug: Methotrexate;   Drug: Methotrexate / Hydrocortisone / Cytarabine;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Vincristine;   Drug: Pegaspargase
27 Recruiting Study Evaluating the Efficacy and Safety of JCAR015 in Adult B-cell Acute Lymphoblastic Leukemia (B-ALL)
Condition: Acute Lymphoblastic Leukemia
Intervention: Biological: JCAR015 (CD19-targeted CAR T cells)
28 Not yet recruiting Study of Pembrolizumab in Combination With Ublituximab and TGR-1202 in Patients With Relapsed-refractory CLL
Condition: Chronic Lymphocytic Leukemia
Interventions: Drug: Pembrolizumab;   Drug: TGR-1202;   Biological: ublituximab
29 Not yet recruiting Study of MK-3475 in Relapsed or Refractory Peripheral T-cell Non-Hodgkin Lymphoma
Condition: Lymphoma, T-Cell, Peripheral
Intervention: Drug: MK-3475
30 Not yet recruiting Study of 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to Treat Niemann-Pick Type C1 (NPC1) Disease
Condition: Niemann-Pick Disease, Type C
Interventions: Drug: HP-β-CD;   Drug: Sham Procedure Control
31 Not yet recruiting CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL
Conditions: Peripheral T-Cell Lymphoma;   Angioimmunoblastic T Cell Lymphoma;   ALK-negative Anaplastic Large Cell Lymphoma;   Enteropathy Associated T Cell Lymphoma;   Subcutaneous Panniculitis Like T Cell Lymphoma;   Acute Adult T-Cell Leukemia/Lymphoma
Interventions: Drug: CEOP/IVE/GDP chemotherapy regimen;   Drug: CEOP chemotherapy regimen for 8 cycles
32 Recruiting P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens
Condition: Lymphoma, Extranodal NK-T-Cell
Interventions: Drug: gemcitabine;   Drug: oxaliplatin;   Drug: pegaspargase
33 Not yet recruiting Study of Ibrutinib in Combination With Rituximab and Lenalidomide
Conditions: Lymphoma;   Follicular Lymphoma (FL)
Interventions: Drug: Lenalidomide;   Drug: Rituximab;   Drug: Ibrutinib
34 Not yet recruiting A Study of Belinostat With Dexamethasone, Cytarabine, Cisplatinum (RDHAP) Chemotherapy in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Belinostat;   Drug: Rituximab;   Drug: Cisplatin;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Ciprofloxacin;   Drug: Fluconazole
35 Recruiting High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma
Condition: Diffuse Large B-cell-lymphoma
Interventions: Drug: Arm A (Fortecortin®-ETOPOPHOS®-IFO-cell®-CARBO-cell®);   Drug: Arm B (TEPADINA®-CARMUBRIS®-Busilvex®)
36 Recruiting Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL)
Condition: Diffuse Large B-Cell Lymphoma
Interventions: Drug: Metformin;   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: pegfilgrastim
37 Not yet recruiting Trial of Immune Reconstitution With Activated T-Cells Following Lymphodepleting Chemotherapy in Patients With Chronic Lymphocytic Leukemia (CLL)
Conditions: Leukemia;   Chronic Lymphocytic Leukemia
Interventions: Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Fludarabine monophosphate;   Drug: Bendamustine;   Biological: Activated T-Cell Infusion;   Drug: Lenalidomide;   Behavioral: Phone Calls
38 Recruiting Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission
Conditions: Stage III Diffuse Large B-Cell Lymphoma;   Stage IV Diffuse Large B-Cell Lymphoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pidilizumab
39 Not yet recruiting A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: Lenalidomide;   Drug: Obinutuzumab;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone
40 Recruiting Prevention of Lymphedema Among Breast Cancer Patients Through Implementation of an Integrative Therapy Program (ITP)
Condition: Lymphedema
Intervention: Other: ITP

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years